CFDE Data Portal | Search PROM1

	Label	Description
	PROM1 Gene (Entity type)	ENSG00000007062 - prominin 1
	PLOD3 Gene (Entity type)	ENSG00000106397 - procollagen-lysine,2-oxoglutarate 5-dioxygenase 3
	ACADM Gene (Entity type)	ENSG00000117054 - acyl-CoA dehydrogenase medium chain
	PPP2R5C Gene (Entity type)	ENSG00000078304 - protein phosphatase 2 regulatory subunit B'gamma
	PROM1 associations Collection (Entity type)	Associations for PROM1_associations
	NDUFB6 Gene (Entity type)	ENSG00000165264 - NADH:ubiquinone oxidoreductase subunit B6
	COQ2 Gene (Entity type)	ENSG00000173085 - coenzyme Q2, polyprenyltransferase
	MED28 Gene (Entity type)	ENSG00000118579 - mediator complex subunit 28
	GSE135514 8 V 7 DASATINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS

PROM1

ENSG00000007062 - prominin 1

PLOD3

ENSG00000106397 - procollagen-lysine,2-oxoglutarate 5-dioxygenase 3

ACADM

ENSG00000117054 - acyl-CoA dehydrogenase medium chain

PPP2R5C

ENSG00000078304 - protein phosphatase 2 regulatory subunit B'gamma

PROM1 associations

Associations for PROM1_associations

NDUFB6

ENSG00000165264 - NADH:ubiquinone oxidoreductase subunit B6

COQ2

ENSG00000173085 - coenzyme Q2, polyprenyltransferase

MED28

ENSG00000118579 - mediator complex subunit 28

GSE135514 8 V 7 DASATINIB HUMAN DN

A Gene Set from LINCS

GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 3 v 2 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.